Phase 3 BELLWAVE-010: Nemtabrutinib Plus Venetoclax Versus Venetoclax Plus Rituximab (VR) in Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Özet
- Basım Tarihi: 2024
- Dergi Adı: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
- Ankara Üniversitesi Adresli: Evet